About Tim Thoelecke

Tim Thoelecke, C-SAPA, is the founder of InOut Labs. InOut Labs is a nationwide provider of employee drug testing services, and your best choice for affordable, direct-to-consumer health tests. Tim Thoelecke is a one of an elite group of Certified Substance Abuse Program Administrators. He is a graduate of Duke University, the Keller Graduate School of Business, the Goldman Sachs 10,000 Small Businesses program, and he founded InOut Labs to help employers and individuals take control of their health, culture and safety. InOut Labs' websites: www.inouotlabs.com (Drug Testing and DOT Compliance) www.screeningwise.com (Background Screening) www.drugtestingshop.com (E-commerce site for drug tests) www.labtestshop.com (E-commerce site for medical tests). InOut Labs is BBB Accredited with an A+ Rating.

InOut Labs Launches InstaCLEAR: A Virtual Drug Testing Solution for the Modern Workforce

InOut Labs, a national leader in drug testing and employment screening solutions, is proud to announce the launch of InstaCLEAR Virtual Drug Testing, powered by Novir. This new platform brings drug testing into the digital age with a real-time, fully supervised, oral fluid drug test that allows employers and individuals to test from virtually [...]

By |June 21st, 2025|Press|Comments Off on InOut Labs Launches InstaCLEAR: A Virtual Drug Testing Solution for the Modern Workforce

Why Drug Testing Cutoff Levels Matter: Ensuring Accuracy and Fairness

Why Drug Testing Cutoff Levels Matter Drug testing plays a vital role in workplaces, law enforcement, and sports. However, not every test result is reported as positive or negative—cutoff levels determine whether a sample is considered a pass or fail. These levels prevent false positives, reduce legal risks, and ensure fair testing practices. But [...]

By |March 19th, 2025|Uncategorized|Comments Off on Why Drug Testing Cutoff Levels Matter: Ensuring Accuracy and Fairness

Can a Driver Complete a Return-to-Duty (RTD) Test Without an Employer? A Step-by-Step Guide

Yes. According to 49 CFR 382.705(b)(1)(ii), drivers who do not have a current or prospective employer subject to FMCSA drug and alcohol regulations can still complete the return-to-duty (RTD) test process. By registering as an owner-operator in the Clearinghouse and designating a consortium/third-party administrator (C/TPA), they can take an RTD test and report the [...]

By |February 23rd, 2025|Uncategorized|Comments Off on Can a Driver Complete a Return-to-Duty (RTD) Test Without an Employer? A Step-by-Step Guide

Designated Employer Representative (DER) Must Remove Employee from Safety-Sensitive Functions While Awaiting Split Specimen Test Results

DER Remove Employee: Immediate Action Required Drug testing compliance is essential in safety-sensitive industries, and the Designated Employer Representative (DER) must take immediate action when an employee tests positive for drugs. Without hesitation, the DER remove employee from safety-sensitive duties after receiving a verified positive drug test result. This guide explains the split specimen [...]

By |February 10th, 2025|DOT Compliance, DOT Drug Testing|Comments Off on Designated Employer Representative (DER) Must Remove Employee from Safety-Sensitive Functions While Awaiting Split Specimen Test Results

What Happens When a Collector Finds Items Used to “Beat” A Drug Test?

Drug Test Cheating: Understanding and Preventing Tampering in FMCSA-Regulated Industries Drug testing plays a critical role in maintaining the integrity and safety of FMCSA-regulated industries. However, drug test cheating remains a persistent challenge, with individuals attempting to tamper with or adulterate their specimens. The rules under 49 CFR § 40.61 ensure a foolproof testing [...]

By |February 2nd, 2025|drug test cheating, drug testing|Comments Off on What Happens When a Collector Finds Items Used to “Beat” A Drug Test?

What Does the MRO Report to the DER When There is a Positive, Adulterated, or Substituted Test Result?

MRO Report to DER: Key Responsibilities and Process The MRO report to DER is a crucial step in workplace drug testing. The Medical Review Officer (MRO) serves as a vital link in ensuring accurate drug testing processes. Before informing the Designated Employer Representative (DER) of any test results, the MRO verifies the findings with [...]

By |January 24th, 2025|DOT Compliance, DOT Drug Testing, FMCSA Clearinghouse|Comments Off on What Does the MRO Report to the DER When There is a Positive, Adulterated, or Substituted Test Result?

Cancelled Random Tests Do Not Count Toward Minimum Requirements

When it comes to maintaining compliance with the Department of Transportation (DOT) regulations, understanding how cancelled tests are handled is crucial. Therefore, random drug and alcohol tests play an integral role in ensuring safety within industries regulated by the Federal Motor Carrier Safety Administration (FMCSA). However, cancelled random tests present unique challenges. In this [...]

By |January 22nd, 2025|DOT Drug Testing|Comments Off on Cancelled Random Tests Do Not Count Toward Minimum Requirements

When You Hire A New CDL Driver (FMCSA)

When you hire a new CDL driver, you must complete several steps before the driver becomes eligible to drive. When You Hire a New CDL Driver Ensure the driver is registered in the FMCSA Clearinghouse to conduct a Pre-Employment Full Query. You must receive a “Driver Not Prohibited” Pre-Employment Query result, or the driver [...]

By |January 3rd, 2025|DOT Compliance, DOT Drug Testing, Drug Testing Policy, FMCSA Clearinghouse|Comments Off on When You Hire A New CDL Driver (FMCSA)

CDL Drivers Take Note: CBD is Not Regulated and May Generate a THC Positive

Cannabidiol (CBD) has gained popularity for its purported therapeutic benefits, such as pain relief, reduced anxiety, and stress management. However, employees subject to FMCSA drug testing regulations should be cautious when using CBD products. Despite its growing popularity, CBD is not regulated and may contain trace amounts of THC, which can lead to a [...]

By |December 19th, 2024|Drugs, FMCSA Clearinghouse, Marijuana|Comments Off on CDL Drivers Take Note: CBD is Not Regulated and May Generate a THC Positive

Key Takeaways from Quest Diagnostics Drug Testing Index 2023

Quest Diagnostics annual drug testing index (DTI) report for 2023 is released. DTI also provides valuable insights into drug use in the workforce and covers a range of illicit, legal, and prescription drugs. The report can help employers make informed decisions and changes in their drug testing programs. In this blog post, we also [...]

By |July 15th, 2024|Blog, DOT Drug Testing, Drug Testing Policy|Comments Off on Key Takeaways from Quest Diagnostics Drug Testing Index 2023